Physicochemical Properties
Molecular Formula | C22H26CLF3N2O |
Molecular Weight | 426.9082 |
Exact Mass | 390.192 |
Elemental Analysis | C, 61.90; H, 6.14; Cl, 8.30; F, 13.35; N, 6.56; O, 3.75 |
CAS # | 1350920-22-7 |
PubChem CID | 46912157 |
Appearance | Solid powder |
LogP | 4.513 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 5 |
Heavy Atom Count | 28 |
Complexity | 497 |
Defined Atom Stereocenter Count | 0 |
SMILES | FC(C1C=CC(=CC=1)CN1CCCC(C(N(C)CC2C=CC=CC=2)=O)C1)(F)F |
InChi Key | GBBPVLQIMJCBJF-UHFFFAOYSA-N |
InChi Code | InChI=1S/C22H25F3N2O.ClH/c1-26(14-17-6-3-2-4-7-17)21(28)19-8-5-13-27(16-19)15-18-9-11-20(12-10-18)22(23,24)25;/h2-4,6-7,9-12,19H,5,8,13-16H2,1H3;1H |
Chemical Name | 1-(4-Trifluoromethyl-benzyl)-piperidine-3-carboxylic acid benzyl-methyl-amide Hydrochloride |
Synonyms | T.cruzi Inhibitor; MDK-1088; MDK1088; MDK 1088; MDK-1088 HCl; MDK-1088 hydrochloride |
HS Tariff Code | 2934.99.9001 |
Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product requires protection from light (avoid light exposure) during transportation and storage. |
Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
ln Vitro | Trypanosoma cruzi replication is inhibited by T.cruzi-IN-1, with a toxicity IC50 of 61.6 μM[1]. |
References | [1]. Germain AR, et al. Identification of small-molecule inhibitors of Trypansoma cruzi replication. Bioorg Med Chem Lett. 2011 Dec 1;21(23):7197-200. |
Solubility Data
Solubility (In Vitro) | DMSO : ~50 mg/mL (~128.06 mM) |
Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 0.71 mg/mL (1.82 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 7.1 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 0.71 mg/mL (1.82 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 7.1 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 0.71 mg/mL (1.82 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 7.1 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly. Solubility in Formulation 4: 10% DMSO+40% PEG300+5% Tween-80+45% Saline: ≥ 0.71 mg/mL (1.82 mM)  (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 2.3424 mL | 11.7121 mL | 23.4241 mL | |
5 mM | 0.4685 mL | 2.3424 mL | 4.6848 mL | |
10 mM | 0.2342 mL | 1.1712 mL | 2.3424 mL |